BioPharm Laboratories
Generated 5/10/2026
Executive Summary
BioPharm Laboratories, LLC, founded in 2002 and headquartered in San Diego, is a private specialty manufacturer of high-quality bovine thrombin and bovine serum albumin for the global diagnostics market. The company's core products are essential for defibrinating plasma to produce serum matrices used as controls, standards, and in polyclonal antibody production, as well as for cleaving fusion protein tags. With over two decades of operational history, BioPharm has established a reputation for reliability and quality in a niche segment of the life sciences supply chain. However, given its private status and lack of disclosed financials or growth metrics, its overall market penetration and competitive landscape are not publicly assessable. The company appears well-positioned as a steady supplier to diagnostic companies, but its scale and innovation pipeline remain opaque.
Upcoming Catalysts (preview)
- Q4 2026Expansion of product line into recombinant proteins40% success
- Q2 2027Strategic partnership with major diagnostics OEM30% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)